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Background: Nitric oxide (NO) is an important phys-
iological mediator of vascular tone and is involved in
pathophysiology  of  septic  shock.  Although  plasma
nitrite is a stable end product of NO oxidation derived
from endogenous NO, the plasma nitrite level is also
easily affected by the intake of various foods, bacterial
products and renal functional status.
Aims: We  propose  an  excellent  alternative  assay
technique for measuring endogenous NO production.
Methods: We  measured  the  nitrite level  in  cultured
vascular  smooth  muscle  cells  (SMC)  treated  with
serum obtained from patients with sepsis (4 patients),
by means of a chemiluminescence detector.
Results: The nitrite concentrations in such cells were
significantly higher as compared to those in the cells
treated with normal serum. Moreover, the increased
nitrite levels in the SMC treated with the sera obtained
from patients with sepsis were completely inhibited
by L-nitroarginine (1 mmol/L), a nitric oxide synthase
inhibitor.
Conclusion: These data suggest that this assay method
enable  us  to  know  the  ability  of  endogenous  NO
production in each patient.
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Introduction
Various factors are  involved  in  the pathogenesis  of
septic shock. Among them, recent interest has been
centred on the nitric oxide (NO) pathway.1 Evidence
for its involvement stems from the observation that a
specific NO synthase inhibitor prevented endotoxin-
induced hypotension in an experimental model2 and
that  in  patients  with  septic  shock  resistant  to  the
treatment  with  a  certain  NOS  inhibitor  and  to  an
increase in blood pressure.3In order to determine the
influence of sepsis on the endogenous NO production
in humans, plasma nitrite levels were conventionally
measured, because nitrite is a very stable oxidation
product. However, a drawback of this method is that
plasma nitrite is derived from not only endogenous
NO, but also from various foods and bacterial products.
In addition, nitrite levels are easily affected by the renal
functional status.4Therefore, we consider, it is almost
impossible  to measure  endogenously  produced NO
alone in the blood. We tried to measure the endoge-
nous NO producing activity of patients with sepsis by
means of cultured vascular smooth muscle cells (SMC).
Sera from patients with sepsis induced NO production
in the SMC, but those from control subjects did not.
These data suggest  that our assay system can be
useful  for  the  evaluation  of  the  endogenous  NO
producing activity in pathological conditions such as
sepsis.
Patients and methods
Patient
Four  patients  (1  male  and  3  female),  aged  47–68
years,  who  were  diagnosed  as  having  sepsis  were
recruited in the study. Patients were judged clinically
to have septicaemia if they had a high fever (>38.5°C)
and tachycardia (>110/min). All the patients had the
haematological  malignancies  (1  case  of  acute  lym-
phoblastic leukemia, 1 of myelodysplastic syndrome
and 2 of chronic myeloblastic leukemia), as shown in
Table  1.  Blood  samples  were  obtained  within  24
hours  of  the  diagnosis  of  septicaemia.  Serum  was
separated immediately by centrifugation, frozen, and
kept at –80°C until analysis.
Reagents
L-nitroarginine  and  D-nitroarginine  were  purchased
from Sigma Co. Ltd (MO).
Cell culture
Bovine  vascular  SMCs were isolated from  a  carotid
artery and cultured as described previously.5The cells
were  grown  in  modified  Eagle’s  medium  (MEM;
GIBCO,  NY)  supplemented  with  10%  foetal  calf
serum  (JRH  Biosciences,  Lenexa,  KS),  and  used
between passages 11 and 21. For the studies reported
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200mm2) (Iwaki Glass, Tokyo) containing MEM sup-
plemented with 10% FCS and maintained at 37°C in
an incubator under a humidified atmosphere of 95%
air and 5% CO2.
NO measurement
Confluent SMCs were washed twice with MEM and
treated  with  MEM  containing  10%  serum  obtained
from a patient with sepsis. After 24 hours, the amount
of NO released from the SMC was measured as nitrite
in this medium and in aqueous solution by means of
a chemiluminescence detector (Silvers Instruments,
Inc.,  CO).6,7 Nitrite  concentration  was  determined
using  sodium  nitrite  (NaNO2, Wako,  Osaka)  as  the
standard. The background signal in the medium was
subtracted from each measured value. The NO pro-
duction was calculated as follows;
NO production = test value – blank value
Blank  means  the  nitrite  from  MEM  supplemented
with serum.
Lipopolysacharide  (LPS;  Sigma  Co  Ltd,  MO)
induced  nitrite production  from  SMC  for 24  hours
(0.5ng/ml of LPS: 27.0±4.3pmol/well, 1ng/ml of LPS:
40.2±6.9pmol/well).
Results
Sera from patients with sepsis induced NO produc-
tion from SMC. In Table 1, clinical data on 4 patients
with  sepsis  are  shown.  None  of  the  patients  had
hypotension.  Three  cases  showed  neutropenia
(<500/ml). The  samples  from  all  these  patients  sig-
nificantly induced nitrite production in cultured SMC
(5.95±1.5pmol/well,  p<0.05  vs.  normal  subjects;
0.50±0.02pmol/well).  On  the  other  hand,  serum
obtained from the same patients after the treatment
from sepsis did not induce nitrite production in the
SMC  (0.86±0.2pmol/well),  as  shown  in  Fig.  1(A).
Furthermore,  sera  obtained  from  normal  subjects
(N=4) also did not increase the nitrite production in
the SMC (0.38±0.08pmol/well).
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Table 1. Characteristics of patients with sepsis
Age/sex Diseases Blood pressure
(mm Hg)
WBC (/ml)/Seg
(%)
CRP
(mg/ml)
Endotoxin
(pg/ml)
Case 1 68/M MDS (RAEB) 118/70 600/26 16.4 26.3
Case 2 48/F CML 130/72 6300/0 3.8 NE
Case 3 47/F ALL 110/70 3500/8 1.1 NE
Case 4 68/F CML 108/64 8800/64 6.2 17.2
WBC: white blood cells, Seg: segmented neutrophils, CRP: C reactive protein. MDS: myelodysplastic syndrome, RAEB: refractory anemia with
excess of blast, ALL: acute lymphoblastic leukemia, CML: chronic myeloblastic leukemia.
FIG. 1. (A) Nitrite production in vascular smooth muscle cells
treated with serum obtained from the patients with sepsis.
Vascular smooth  muscle cells (SMC)  were  grown  to  con-
fluence on a 24-well dish. Nitrite levels were measured in the
medium of the SMC treated with the serum for 24 hours, as
described in Patients and methods. Four patients (cases 1–4
in the Table 1) were analysed. The data represent the mean
of  8  wells. (B)  Effect  of  a  nitric  oxide  synthase inhibitor,
L-nitroarginine, on the nitrite levels in the SMC treated with
serum obtained from patients with sepsis. Vascular smooth
muscle cells (SMC) were grown to confluence on a 24-well
dish. Nitrite levels were measured in the medium of the SMC
treated  with  the  serum  for  24  hours,  in  the  presence  or
absence  of  L-nitroarginine  (1mmol/L)  or  D-nitroarginine
(1mmol/L). These experiments were performed for Cases 1
and 4 described in Table 1. The data represent the means
±SEM of 8 wells. Each experiment was repeated 3 times.Effect of a specific NOS inhibitor on the NO
production induced by the septic sera
L-nitroarginine (1mmol/L), a specific NOS inhibitor,
was concomitantly added to the cultured SMC treated
with  MEM  containing  10%  sera  obtained  from  the
patients with sepsis (cases 1 and 4). L-nitroarginine
suppressed the increase in nitrite level as shown in
Fig.  1(B).  On  the  other  hand,  D-nitroarginine,  an
optical isomer, which does not inhibit NOS activity,
did not affect the increase in nitrite level.
Discussion
L-nitroarginine, but not D-nitroarginine, inhibited the
production of nitrite in cultured SMC induced by sera
obtained from  patients with  sepsis, suggesting  that
the nitrite was derived from iNOS in the SMC. Using
the proposed assay technique, the activity of endoge-
nous  NO  production  can  be  evaluated.  Even  sera
obtained from patients with sepsis who did not have
hypotension induced an increase in the nitrite pro-
duction in the SMC. We measured the nitrite levels in
the  medium  of  cultured  SMC  treated  with  serum
obtained from two patients with septic shock (15.2
and 17.5pmol/well, respectively). Despite evaluation
of only two cases, this assay technique is considered
beneficial  for  the  severity  of  sepsis.  It  has  been
previously  reported  that  the  plasma  nitrite  levels
increased in patients with sepsis.8 However, plasma
nitrite is derived from not only endogenous NO, but
also  from  various  foods  and  bacterial  products.  In
sepsis, bacteria induce the release of massive amounts
of nitrite in the blood. We consider that the plasma
nitrite level does not directly reflect the endogenous
NO production.
Our  assay  method  measures  only  the  ability  for
the  endogenous  NO  production  of  an  individual
person. However, there are also some disadvantages
of  this  technique.1 The  substances  that induce NO
production  are  unclear.  We  consider  that  various
interleukins, such as interleukin 1 and 6, and so on
in the serum may induce iNOS in SMC.2 Even in the
case  of  septic  shock, the  endogenous  NO  produc-
tion in SMC is low (pmol/well). Thus, it is possible
that  SMC  are  not  adequate  as  target  cells.  On  the
other hand, since the NO production in macrophage
cell  lines  is  massive,  in  further  experiments,  we
propose  to  measure  the  nitrite  levels  using  macro-
phage  cell  lines.  Moreover,  because  only  four
patients with sepsis were evaluated in this study, we
propose  to  enrol  many  patients  with  sepsis  and
septic  shock  to  evaluate  the  endogenous  NO  pro-
ducing activity in  the patients.
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